Invasive Mycoses: Emerging Paradigms & Practical Applications

CME.jpg

IDWeek 2016

Invasive Mold Infections: Emerging Approaches is an interactive, enduring activity based on a satellite symposium held during IDWeek 2016. This activity is designed to aid specialists in the treatment of invasive mold infections, complete with up-to-date diagnostics and relevant treatment options pertinent to the optimal management within a historically challenging and ever-changing field. We hope that you find this short, enduring activity helpful as you manage these challenging infections.

Original Activity:

Invasive Mycoses: Emerging Paradigms & Practical Applications is an enduring activity based on content presented at the 2016 MSGERC symposium at ASM Microbe. With content spanning from updates on diagnostics and pharmacologic considerations for therapies to challenges in the management of invasive aspergillosis, invasive mucormycosis, and breakthrough infections, this activity addresses key clinical issues for optimal invasive fungal disease (IFD) management. In addition, we have also included fungus-specific updates from the Microbe meeting in the companion Mycology Minutes™ activity (see link below). We hope you find these activities helpful as you hone and update your strategies for managing these difficult infections.   

CME Information

Update From IDWeek 2016:

Title: Invasive Mold Infections: Emerging Approaches

Release Date:12/31/2016
Expiration Date: 12/30/2017
Estimated Time to Complete the Activity: 1 hr
Media: Text-based presentation, interactive

Original Activity:

Title: Invasive Mycoses: Emerging Paradigms & Practical Applications

Release Date:9/25/2016
Expiration Date: 9/24/2017
Estimated Time to Complete the Activity: 2.5 hrs
Media: Text-based presentation, interactive

Statement of Need

Update From IDWeek 2016:

With increasing numbers of immunocompromised patients at risk for invasive mold infections, it is important to stay abreast of the emerging strategies to manage these particularly difficult infections. Recently, the IDSA issued new invasive aspergillosis guidelines and the experience and literature is growing related to the management of mucormycosis, fusariosis, and other rare molds. This update provides a brief overview over new strategies you can use to break the mold in the management of these devastating infections.

Original Activity:

Recently, updated literature and guidelines have been released regarding the management of invasive fungal infections. This information spans from documentation of emerging resistance trends, to diagnostic criteria and options, to updated IDSA guidelines in invasive candidiasis and invasive aspergillosis, to more pharmacologically oriented information regarding newer antifungal therapeutic options. Expert-led discussion should help put these findings/guidelines in context and provide insights into how to translate them in clinical practice. Join this multidisciplinary international panel as they evaluate emerging paradigms in antifungal management as well as their practical application in multidisciplinary case examples.

Learning Objectives

Update From IDWeek 2016:

After completing this activity, the participants should be better able to:

  • Compare available and emerging diagnostics for the early diagnosis and management of invasive mold infections
  • Evaluate the evidence base behind different strategies for managing invasive aspergillosis, invasive mucormcycosis, and other rare molds
  • Select appropriate, evidence-based fungal diagnostics and therapies based on specific patient characteristics

Original Activity:

After completing this activity, the participants should be better able to:

  • Compare available and emerging diagnostics for the early diagnosis and management of invasive fungal disease
  • Evaluate therapeutic options for IFD management in terms of level of evidence and appropriateness in different populations
  • Choose treatments that will optimize the pharmacologic aspects of antifungal therapy
  • Select appropriate evidence-based antifungal diagnostics and therapies based on specific patient characteristics

Target Audience

This activity is directed to specialists in infectious diseases, hospital medicine, hematology/oncology, pathology, medical microbiology, critical care, pharmacy, and surgery, as well as other healthcare providers responsible for the management of invasive mycoses.

Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the University of Nebraska Medical Center, Center for Continuing Medical Education; Terranova Medica, LLC; and the Mycoses Study Group Education & Research Consortium.

The University of Nebraska Medical Center, Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Access these courses here

CME/CPD